Hjem › Øycelleadenom › Maryland
Kliniske studier for Øycelleadenom i Maryland
4 studier for Øycelleadenom søker deltakere på steder i Maryland.
Byer i Maryland
Offisiell studietekst (engelsk)
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
- Investigative Site, Bethesda
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT06881992Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
- Johns Hopkins Hospital-Sidney Kimmel Comprehensive Cancer Center - Developmental Therapeutics ( Site 0108), Baltimore
- National Institutes of Health ( Site 0125), Bethesda
RekruttererFase 2
Alder 12 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT04924075Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy
- Research Facility, Glen Burnie
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 30. mar. 2026 · NCT05477576Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
- Mercy Medical Center, Baltimore
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 15. des. 2025 · NCT05040360Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.